Renaissance Technologies - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$358
-62.9%
48,302
-52.7%
0.00%0.0%
Q1 2023$966
-43.2%
102,200
-36.0%
0.00%
-50.0%
Q4 2022$1,700
-99.7%
159,600
+103.8%
0.00%
+100.0%
Q3 2022$578,000
+107.9%
78,300
+35.7%
0.00%
Q2 2022$278,00057,7000.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 37,500$225,0000.16%
SABBY MANAGEMENT, LLC 73,366$441,0000.06%
GSA CAPITAL PARTNERS LLP 56,673$341,0000.04%
GOODWIN DANIEL L 10,000$60,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$535,0000.01%
EMFO, LLC 1,666$10,0000.01%
Virtu Financial LLC 14,020$84,0000.01%
Retirement Group, LLC 1,129$17,0000.01%
BLAIR WILLIAM & CO/IL 86,866$522,0000.00%
Hartford Financial Management Inc. 598$4,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders